Fig. 1From: The impact of age on the implementation of evidence-based medications in patients with coronary artery disease and its prognostic significance: a retrospective cohort studyDischarge prescription of EBMs for CAD patients stratified by age (P < 0.05 for trend in EBMs, including aspirin, clopidogrel, dual antiplatelet, statins, beta-blockers, and ACEIs or ARBs, according to age). Abbreviations: EBMs, evidence-based medicines; CAD, coronary artery disease; ACEI, angiotensin-converting enzyme inhibitor; ARBs, angiotensin receptor blockersBack to article page